These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 16296411)

  • 61. Pre-emptive kidney transplantation: the attractive alternative.
    Asderakis A; Augustine T; Dyer P; Short C; Campbell B; Parrott NR; Johnson RW
    Nephrol Dial Transplant; 1998 Jul; 13(7):1799-803. PubMed ID: 9681731
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potential influence of dialysis modality on post-transplantation diabetes mellitus risk.
    Courivaud C; Ducloux D
    Nephrol Dial Transplant; 2011 Jun; 26(6):2063; author reply 2063-4. PubMed ID: 21444363
    [No Abstract]   [Full Text] [Related]  

  • 63. [The role of dialysis in the treatment of terminal renal insufficiency in children].
    Picon G; Falque V; Caniot E; Dispa C; Bourlier-Najean B; Legre R; Viard L; Guys JM
    Ann Pediatr (Paris); 1991 Mar; 38(3):157-64. PubMed ID: 2039183
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pediatric dialysis and renal transplantation in Kuwait over the past 11 years.
    El-Reshaid K; Kapoor MM; Nampoory MR; El-Reshaid W; Johny KV
    Pediatr Nephrol; 1999 Apr; 13(3):259-64. PubMed ID: 10353418
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Actuarial analysis of patient survival and dropout with various end-stage renal disease therapies.
    Prowant B; Nolph KD; Dutton S; Van Stone J; Whittier FC; Ross G; Moore H
    Am J Kidney Dis; 1983 Jul; 3(1):27-31. PubMed ID: 6346864
    [No Abstract]   [Full Text] [Related]  

  • 66. [The incidence of ESRD in 2011].
    Briançon S; Lange C; Thibon P; Jacquelinet C; Stengel B
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S19-37. PubMed ID: 24119582
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Peritoneal dialysis - an alternative to hemodialysis in the center].
    Vychytil A; Hörl WH
    Wien Med Wochenschr; 2013 Jun; 163(11-12):253-4. PubMed ID: 24000394
    [No Abstract]   [Full Text] [Related]  

  • 68. [How to promote kidney transplantation in Japan: perspective from a nephrologist].
    Morozumi K; Takeda A
    Nihon Jinzo Gakkai Shi; 2004 Feb; 46(2):52-8. PubMed ID: 15058104
    [No Abstract]   [Full Text] [Related]  

  • 69. Optimal peritoneal dialysis for patients from Hong Kong.
    Lai KN; Lo WK
    Perit Dial Int; 1999; 19 Suppl 3():S26-31; discussion S32-4. PubMed ID: 10433549
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of children in the U.S. with end-stage renal disease (ESRD).
    Lewy JE
    Med Arh; 2001; 55(4):201-2. PubMed ID: 11769443
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Peritoneal dialysis and renal transplantation.
    Lobbedez T; Lecouf A; Abbadie O; Ficheux M; de Ligny BH; Ryckelynck JP
    Contrib Nephrol; 2009; 163():250-256. PubMed ID: 19494621
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Terminal renal insufficiency and indication for kidney transplantation].
    Protzel C; Führer A; Hakenberg OW
    Urologe A; 2015 Oct; 54(10):1356-61. PubMed ID: 26459577
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dialysis modality selection among patients attending freestanding dialysis facilities.
    Kendix M
    Health Care Financ Rev; 1997; 18(4):3-21. PubMed ID: 10175611
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Switching and the definition of modality in end-stage renal disease treatment.
    Smith DG; Wheeler JR
    Med Care; 1987 Dec; 25(12):1168-78. PubMed ID: 3320593
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Renal replacement therapy in yemen.
    Sheiban AK; Yehia A; Mohamed YA; Hajar AR
    Saudi J Kidney Dis Transpl; 1996; 7(3):313-4. PubMed ID: 18417950
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Specific and nonspecific immunoregulatory factors and renal transplantation.
    Donnelly P; Henderson R; Fletcher K; Stratton A; Lennard T; Wilson R; Proud G; Taylor R
    Transplantation; 1987 Oct; 44(4):523-8. PubMed ID: 3313839
    [TBL] [Abstract][Full Text] [Related]  

  • 77. End-stage renal disease treatment modality and patients' quality of life. Longitudinal assessment.
    Kutner NG; Brogan D; Kutner MH
    Am J Nephrol; 1986; 6(5):396-402. PubMed ID: 3548354
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dialysis and transplantation affect cerebral abnormalities of end-stage renal disease.
    Michaelis T; Videen JS; Linsey MS; Ross BD
    J Magn Reson Imaging; 1996; 6(2):341-7. PubMed ID: 9132100
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Renal replacement therapy in Kuwait.
    El-Reshaid K
    Saudi J Kidney Dis Transpl; 1994; 5(4):493-7. PubMed ID: 18583778
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nephrology services in Pakistan.
    Ali Jaffar Naqvi S
    Nephrol Dial Transplant; 2000 Jun; 15(6):769-71. PubMed ID: 10831626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.